Aquestive Therapeutics, Inc. AQST Other — Total Selling expenses

Other product segments

Similar metrics at other companies

MNKDAll Other Segments — Selling Expense

$38.57M+180%

MUROther — Selling and general expenses

$2.1M+10.5%

CEOther — Selling, General and Administrative Expense

$105M+9.4%

MTRNOther — Selling, general, and administrative expense

$6.76M+4.6%

GOReportable Segment — Other selling expenses

$78.22M+4.9%

AMRCAll Other — Selling, general and administrative expenses

$3.43M-0.8%

Questions, answered.

What is Aquestive Therapeutics, Inc.'s other — total selling expenses?

Aquestive Therapeutics, Inc. (AQST) reported other — total selling expenses of $277K in Q1 2026.

How has Aquestive Therapeutics, Inc.'s other — total selling expenses changed year-over-year?

Aquestive Therapeutics, Inc.'s other — total selling expenses decreased by 87.8% year-over-year, from $2.26M to $277K.

What is the long-term trend for Aquestive Therapeutics, Inc.'s other — total selling expenses?

Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s other — total selling expenses has grown at a 336.5% compound annual growth rate (CAGR), from $775K to $14.77M.

What does other — total selling expenses mean?

This metric aggregates all costs associated with the sales and distribution efforts of the segment, including personnel, commissions, and promotional activities. It reflects the resources deployed to capture market share and drive revenue growth for the segment's specific product portfolio. Analyzing this expense provides insight into the segment's sales force productivity and the cost-to-acquire customers within its target market.